← Eichor
Study identifier: NCT06040125 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

Condition: PROSTATE CANCER · Metastatic Prostate Cancer · Metastatic Prostate Carcinoma  ·  Sponsor: Dana-Farber Cancer Institute

PhaseNA
Planned participants80
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and sarcopenic status and disease progression outcomes among pre-frail/frail metastatic prostate cancer patients receiving androgen deprivation therapy (ADT). The names of the study intervention involved in this study is: • Supervised circuit training (aerobic and resistance exercise regimen)

This description comes directly from the study's public registry record.

Talk to the study team

Christina Dieli-Conwright, MD  ·  617-582-8321  ·  ChristinaM_Dieli-Conwright@dfci.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Beth Israel Deaconess Medical CenterBoston, Massachusetts, United StatesNot Yet Recruiting
Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting
Dana-Farber Cancer InstituteBoston, Massachusetts, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06040125